41 related articles for article (PubMed ID: 12885095)
1. 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury.
Tseng KC; Li H; Clark A; Sundem L; Zuscik M; Noble M; Elfar J
EMBO Mol Med; 2016 Dec; 8(12):1409-1420. PubMed ID: 27861125
[TBL] [Abstract][Full Text] [Related]
2. 4-Aminopyridine in pediatric traumatic spinal cord injury: A case report.
Hillaker E; Chen J; Dean J; Yeh N; Sadowsky C; Elfar J
J Spinal Cord Med; 2024 Jun; ():1-3. PubMed ID: 38884567
[TBL] [Abstract][Full Text] [Related]
3. High doses of 4-aminopyridine improve functionality in chronic complete spinal cord injury patients with MRI evidence of cord continuity.
Grijalva I; García-Pérez A; Díaz J; Aguilar S; Mino D; Santiago-Rodríguez E; Guizar-Sahagún G; Castañeda-Hernández G; Maldonado-Julián H; Madrazo I
Arch Med Res; 2010 Oct; 41(7):567-75. PubMed ID: 21167397
[TBL] [Abstract][Full Text] [Related]
4. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury.
Hayes KC; Potter PJ; Wolfe DL; Hsieh JT; Delaney GA; Blight AR
J Neurotrauma; 1994 Aug; 11(4):433-46. PubMed ID: 7837283
[TBL] [Abstract][Full Text] [Related]
5. Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine.
Sun Y; Rodríguez-Rangel S; Zhang LL; Sánchez-Rodríguez JE; Brugarolas P
Sci Rep; 2024 May; 14(1):11105. PubMed ID: 38750155
[TBL] [Abstract][Full Text] [Related]
6. Functional improvement in individuals with chronic spinal cord injury treated with 4-aminopyridine: A systematic review.
Paredes-Cruz M; Grijalva I; Martínez-López YE; Guizar-Sahagún G; Colín-Ramírez E; Rojano-Mejía D
Front Neurol; 2022; 13():1034730. PubMed ID: 36523345
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of 4-aminopyridine accelerates motor functional recovery and improves nerve morphology following sciatic nerve crush injury in mice.
Clark AR; Hsu CG; Talukder MAH; Noble M; Elfar JC
Neural Regen Res; 2020 Jan; 15(1):136-144. PubMed ID: 31535662
[TBL] [Abstract][Full Text] [Related]
8. An overview of pharmacological approaches for management and repair of spinal cord injuries.
Khoshnevisan A; Mardani A; Kamali S
Iran J Psychiatry; 2010; 5(4):119-27. PubMed ID: 22952505
[TBL] [Abstract][Full Text] [Related]
9. 4-aminopyridine toxicity: a case report and review of the literature.
King AM; Menke NB; Katz KD; Pizon AF
J Med Toxicol; 2012 Sep; 8(3):314-21. PubMed ID: 22782458
[TBL] [Abstract][Full Text] [Related]
10. Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons.
Shi R; Sun W
Neurosci Bull; 2011 Feb; 27(1):36-44. PubMed ID: 21270902
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.
Ichim TE; Solano F; Lara F; Paris E; Ugalde F; Rodriguez JP; Minev B; Bogin V; Ramos F; Woods EJ; Murphy MP; Patel AN; Harman RJ; Riordan NH
Int Arch Med; 2010 Nov; 3():30. PubMed ID: 21070647
[TBL] [Abstract][Full Text] [Related]
12. Role of electrical stimulation for rehabilitation and regeneration after spinal cord injury: an overview.
Hamid S; Hayek R
Eur Spine J; 2008 Sep; 17(9):1256-69. PubMed ID: 18677518
[TBL] [Abstract][Full Text] [Related]
13. Functional recovery measures for spinal cord injury: an evidence-based review for clinical practice and research.
Anderson K; Aito S; Atkins M; Biering-Sørensen F; Charlifue S; Curt A; Ditunno J; Glass C; Marino R; Marshall R; Mulcahey MJ; Post M; Savic G; Scivoletto G; Catz A;
J Spinal Cord Med; 2008; 31(2):133-44. PubMed ID: 18581660
[TBL] [Abstract][Full Text] [Related]
14. The use of 4-aminopyridine (fampridine) in demyelinating disorders.
Hayes KC
CNS Drug Rev; 2004; 10(4):295-316. PubMed ID: 15592580
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial.
Grijalva I; Guízar-Sahagún G; Castañeda-Hernández G; Mino D; Maldonado-Julián H; Vidal-Cantú G; Ibarra A; Serra O; Salgado-Ceballos H; Arenas-Hernández R
Pharmacotherapy; 2003 Jul; 23(7):823-34. PubMed ID: 12885095
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial.
Segal JL; Pathak MS; Hernandez JP; Himber PL; Brunnemann SR; Charter RS
Pharmacotherapy; 1999 Jun; 19(6):713-23. PubMed ID: 10391417
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
Lim JH; Muguet-Chanoit AC; Smith DT; Laber E; Olby NJ
PLoS One; 2014; 9(12):e116139. PubMed ID: 25551385
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury.
van der Bruggen MA; Huisman HB; Beckerman H; Bertelsmann FW; Polman CH; Lankhorst GJ
J Neurol; 2001 Aug; 248(8):665-71. PubMed ID: 11569894
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
